Trending
- This 1 lifestyle factor is more dangerous than alcohol and obesity, warns health expert
- New consultancy launches with fresh approach to workplace wellbeing
- iBio Advances IBIO-600 Through First Phase 1 Dose Escalation As Cash And Investments Reach $88 Million
- What Happened to Yoga?
- Keto Diet Outperforms Others for Cardiometabolic Health during Weight Loss: Study
- New Mexico Health Care Authority hosts news conference for Medicaid changes
- Why too many women are prescribed antibiotics for UTIs they don’t have
- New Phase 3b data on Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity
Monday, August 31

